QING XIANG HUANG: Open Payments
NPI 1891812806 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$655 in 29 payments from 8 companies in 2025. Trend: 2023 $802 · 2024 $602 · 2025 $655
Food & beverage: $655
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $209 |
| Azurity Pharmaceuticals, Inc. | 9 | $179 |
| Novo Nordisk Inc | 1 | $124 |
| Eisai Inc. | 2 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Agios Pharmaceuticals, Inc. | 1 | $23 |
| SHIELD THERAPEUTICS INC | 1 | $19 |
Products named: XIFAXAN, HORIZANT, ALVESCO, Leqembi, JARDIANCE, FARXIGA, PYRUKYND, ACCRUFER.
Industry payments across NY — which companies pay providers there.
